Imperial College London

DrGevaGreenfield

Faculty of MedicineSchool of Public Health

Research Fellow in Public Health
 
 
 
//

Contact

 

+44 (0)20 7594 8595g.greenfield Website

 
 
//

Location

 

314Reynolds BuildingCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Woringer,
author = {Woringer, M and Dharmayat, K and Greenfield, G and Bottle, R and Ray, K},
journal = {JMIR Research Protocols},
title = {Feasibility study protocol: The use of American Heart Association’s Cholesterol CarePlan to be delivered as a web application on a smartphone to patients prescribed cholesterol lowering medication},
url = {http://hdl.handle.net/10044/1/61691},
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Background:Adoption of healthy lifestyle and compliance with cholesterol lowering medication reduces the risk of cardiovascular disease (CVD). The use of digital tools and mobile technology may be important for sustaining positive behavioural change. Objectives:Primary objective is to evaluate the feasibility and acceptability of administering the Cholesterol CarePlan web application (app) developed by the American Heart Association (AHA) aimed at improving lifestyle and medication adherence among patients prescribed cholesterol lowering medication. Secondary objective is to assess web app efficacy. Methods:To demonstrate whether the web app may be successfully taken up by patients and be associated with improved clinical and behavioural outcomes, a prospective observational feasibility study will be conducted. The study will aim to recruit 180 study participants being prescribed cholesterol lowering medication for at least 30 days across 14 general practices in London, England. Eligible patients will be invited to use the web app on a smartphone and to come in to general practice for three 20 minute clinical assessments of blood pressure, height, weight, smoking, non-fasting cholesterol over 24 weeks. The feasibility of administering the web app will be judged by recruitment and dropout statistics and by the socio-demographic and co-morbidity profile of study participants, invited patients and all eligible patients. Acceptability will be assessed using patients’ readiness to embrace new technologies, usability of the web app and patient satisfaction. Efficacy of the web app will be assessed by changes in medication adherence and clinical risk factors by levels of web app compliance. Results: Study recruitment will commence in February 2018 and results will be reported in December 2018.
AU - Woringer,M
AU - Dharmayat,K
AU - Greenfield,G
AU - Bottle,R
AU - Ray,K
SN - 1929-0748
TI - Feasibility study protocol: The use of American Heart Association’s Cholesterol CarePlan to be delivered as a web application on a smartphone to patients prescribed cholesterol lowering medication
T2 - JMIR Research Protocols
UR - http://hdl.handle.net/10044/1/61691
ER -